BeOne Medicines AG (6160.HK) HKSE
187.50
+2.5(+1.35%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
187.50
+2.5(+1.35%)
Currency In HKD
Address
Aeschengraben 27
Basel, MA 4051
Switzerland
Phone
41 61 685 19 00
Website
Sector
Healthcare
Industry
Biotechnology
Employees
11000
First IPO Date
August 08, 2018
| Name | Title | Pay | Year Born |
| John V. Oyler | Co-Founder, Executive Chairman & Chief Executive Officer | 22.07M | 1968 |
| Chan Lee | General Counsel & Senior Vice President | 8.37M | 1968 |
| Wang Lai | Global Head of Research & Development | 9.36M | 1977 |
| Xiaobin Wu | President, Chief Operating Officer & GM of China | 14.3M | 1962 |
| Aaron Rosenberg | Chief Financial Officer | 15M | 1977 |
| Xiaodong Wang | Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder | 33.06M | 1963 |
| Marcello Damiani | Chief Technology Officer | 0 | 1970 |
| Titus Ball | VP & Chief Accounting Officer | 0 | 1973 |
| Eleanor Duff | Senior VP & Head of Corporate Communications | 0 | N/A |
| Liza Heapes | Head of Investor Relations | 0 | N/A |
BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.